News - Rilutek

Filter

Current filters:

Rilutek

Popular Filters

New Zealand reaches agreement with Sanofi to fund ALS drug

11-09-2013

New Zealand's Pharmaceutical Management Agency PHARMAC has announce the approval of an agreement with…

Asia-PacificNeurologicalPharmaceuticalRare diseasesRegulationRilutekSanofi

Amyotrophic lateral sclerosis sector lacks new and effective treatment options

06-02-2013

Amyotrophic Lateral Sclerosis (ALS) is the most common type of motor neuron disease (MND), yet the therapeutics…

ALS-02AvicenaMarkets & MarketingMitsubishi TanabeNeurologicalPharmaceuticalRadicutResearchRilutekSanofi

Back to top